 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for FANCA |
 Gene summary |
| Basic gene information | Gene symbol | FANCA |
| Gene name | Fanconi anemia, complementation group A | |
| Synonyms | FA|FA-H|FA1|FAA|FACA|FAH|FANCH | |
| Cytomap | UCSC genome browser: 16q24.3 | |
| Type of gene | protein-coding | |
| RefGenes | NM_000135.2, NM_001018112.1,NM_001286167.1, | |
| Description | Fanconi anemia group A proteinFanconi anemia, complementation group HFanconi anemia, type 1 | |
| Modification date | 20141219 | |
| dbXrefs | MIM : 607139 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000187741 | ||
| HPRD : 06186 | ||
| Vega : OTTHUMG00000173049 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_FANCA | |
| BioGPS: 2175 | ||
| Pathway | NCI Pathway Interaction Database: FANCA | |
| KEGG: FANCA | ||
| REACTOME: FANCA | ||
| Pathway Commons: FANCA | ||
| Context | iHOP: FANCA | |
| ligand binding site mutation search in PubMed: FANCA | ||
| UCL Cancer Institute: FANCA | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | CervixTestis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | CESCTGCT | |
| Reference showing the relevant tissue of FANCA | ||
| Description by TissGene annotations | Cancer gene Fused withOncogene | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for FANCA |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| BRCA | -0.757202253 | -2.664132078 | 1.906929825 | 9.05E-26 | 9.40E-25 |
| COAD | 1.095366235 | -0.476072226 | 1.571438462 | 5.12E-10 | 6.03E-09 |
| KICH | -2.208624534 | -3.642104534 | 1.43348 | 1.55E-06 | 5.68E-06 |
| KIRC | -1.512300645 | -3.642165923 | 2.129865278 | 6.86E-20 | 5.38E-19 |
| LIHC | -0.340612534 | -1.351166534 | 1.010554 | 9.49E-06 | 4.02E-05 |
| LUAD | 0.028102708 | -1.765930051 | 1.794032759 | 1.25E-22 | 3.55E-21 |
| THCA | -1.625330635 | -2.87084928 | 1.245518644 | 6.18E-07 | 2.41E-06 |
| KIRP | -0.953261409 | -3.615698909 | 2.6624375 | 1.45E-12 | 2.26E-11 |
| STAD | 0.845419841 | -1.690177034 | 2.535596875 | 7.39E-08 | 2.14E-06 |
| HNSC | 0.368800583 | -1.127148255 | 1.495948837 | 1.23E-09 | 1.90E-08 |
| LUSC | 0.538339388 | -1.536237083 | 2.074576471 | 9.04E-24 | 1.68E-22 |
| ESCA | 1.138862739 | -1.845391806 | 2.984254545 | 0.000293 | 0.006787833 |
| BLCA | 0.826972308 | -2.117569797 | 2.944542105 | 8.79E-06 | 0.000175934 |
| Top |
| TissGene-miRNA for FANCA |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| UCS | hsa-miR-503-5p | MIMAT0002874 | 0.046 | -0.27 | 56 |
| Top |
| TissGeneMut for FANCA |
| TissGeneSNV for FANCA |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.E542A | STAD | 1 |
| p.G17C | MESO | 1 |
| p.R163H | COAD | 1 |
| p.A786V | STAD | 1 |
| p.L1193R | ESCA | 1 |
| p.L864I | UCEC | 1 |
| p.D1359E | BLCA | 1 |
| p.R917* | SKCM | 1 |
| p.R917* | UCEC | 1 |
| p.K143N | HNSC | 1 |
| p.T1161M | UCEC | 1 |
| p.T1161M | LGG | 1 |
| p.A444V | STAD | 1 |
| p.E1115K | LUAD | 1 |
| p.K1244M | KIRP | 1 |
| p.N1003H | UCEC | 1 |
| p.K143R | OV | 1 |
| p.T256I | SKCM | 1 |
| p.P1222L | BLCA | 1 |
| p.K522R | STAD | 1 |
| p.L1211I | UCEC | 1 |
| p.P442L | SKCM | 1 |
| p.Q869E | LIHC | 1 |
| p.L1056F | LGG | 1 |
| p.L964F | UCEC | 1 |
| p.R1053C | BRCA | 1 |
| p.L617V | PAAD | 1 |
| p.L964I | THYM | 1 |
| p.R1011H | LUAD | 1 |
| p.T1328A | KIRP | 1 |
| p.M365I | COAD | 1 |
| p.Y86N | PRAD | 1 |
| p.Q382H | LUAD | 1 |
| p.P643A | PRAD | 1 |
| p.S616Y | UCEC | 1 |
| p.L185I | UCEC | 1 |
| p.T949N | UCEC | 1 |
| p.A1446T | COAD | 1 |
| p.A181V | DLBC | 1 |
| p.E1351K | HNSC | 1 |
| p.R163H | ESCA | 1 |
| p.R1136G | PRAD | 1 |
| p.S421N | UCEC | 1 |
| p.P643A | STAD | 1 |
| p.Q405H | LUAD | 1 |
| p.E1015K | BRCA | 1 |
| p.F476L | READ | 1 |
| p.R212S | SARC | 1 |
| p.E1310K | BLCA | 1 |
| p.R1204W | UCEC | 1 |
| p.R1084C | BRCA | 1 |
| p.Q326* | BLCA | 1 |
| p.L51M | UCEC | 1 |
| p.G809D | BRCA | 1 |
| p.C422Y | UCEC | 1 |
| p.L424P | LIHC | 1 |
| p.A1103D | BLCA | 1 |
| p.A349V | BLCA | 1 |
| p.G809D | COAD | 1 |
| p.L1075P | LUSC | 1 |
| p.E698K | BLCA | 1 |
| p.R52L | BRCA | 1 |
| p.L530I | LGG | 1 |
| p.R52Q | BLCA | 1 |
| p.N527I | LUAD | 1 |
| p.A47V | ESCA | 1 |
| p.M1024I | BLCA | 1 |
| p.R1409W | CESC | 1 |
| p.K453N | STAD | 1 |
| p.D1147V | LIHC | 1 |
| p.V107I | MESO | 1 |
| p.D533N | HNSC | 1 |
| p.R1419C | PRAD | 1 |
| p.H1286N | PRAD | 1 |
| p.T1161M | LUSC | 1 |
| p.E1214Q | LUSC | 1 |
| p.S734F | LUSC | 1 |
| p.R1439T | BLCA | 1 |
| p.S892F | SKCM | 1 |
| p.E63Q | BLCA | 1 |
| p.L1082F | SKCM | 1 |
| p.N8K | KIRP | 1 |
| p.G1039D | UCEC | 1 |
| p.S75R | ESCA | 1 |
| p.M1151I | SKCM | 1 |
| p.F93L | HNSC | 1 |
| p.S947L | BLCA | 1 |
| p.S1277T | STAD | 1 |
| p.S394C | HNSC | 1 |
| p.S46P | READ | 1 |
| p.L1401V | BLCA | 1 |
| p.P496S | SKCM | 1 |
| p.R951W | COAD | 1 |
| p.E1310Q | CESC | 1 |
| p.R1084C | COAD | 1 |
| p.M717I | COAD | 1 |
| p.L379M | ESCA | 1 |
| p.A1097V | PAAD | 1 |
| p.R1186K | SKCM | 1 |
| p.P643R | KIRP | 1 |
| p.S421G | LIHC | 1 |
| p.S1264Y | BLCA | 1 |
| p.P759S | SKCM | 1 |
| p.P1192L | STAD | 1 |
| p.Q226H | STAD | 1 |
| p.Q940K | ESCA | 1 |
| p.A1097T | COAD | 1 |
| p.Q168E | BRCA | 1 |
| p.R685K | KIRC | 1 |
| p.L477F | LUAD | 1 |
| p.A40E | LUSC | 1 |
| p.V888I | UCEC | 1 |
| p.R52P | CESC | 1 |
| p.P497L | SKCM | 1 |
| p.M731V | ESCA | 1 |
| p.F320L | LUAD | 1 |
| p.E630D | BLCA | 1 |
| p.R435C | BLCA | 1 |
| p.P301S | SKCM | 1 |
| p.P401S | SKCM | 1 |
| p.T1161K | ESCA | 1 |
| p.Q993* | UCEC | 1 |
| p.A47V | COAD | 1 |
| p.S700* | BLCA | 1 |
| p.A152T | THYM | 1 |
| p.A444V | UCEC | 1 |
| p.L875S | LGG | 1 |
| p.P643A | KIRP | 1 |
| p.Q1128K | OV | 1 |
| p.E542* | CESC | 1 |
| Top |
| TissGeneCNV for FANCA |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for FANCA |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | ChiTaRs | NA | BF089164 | PAK1-FANCA | chr11:77086787 | chr16:89833594 | |
| Chimerdb3.0 | ChiTaRs | NA | BF334909 | FANCA-FANCA | chr16:89877785 | chr16:89877617 | |
| Chimerdb3.0 | ChiTaRs | NA | BF744199 | SPG7-FANCA | chr16:89601959 | chr16:89835203 | |
| Chimerdb3.0 | FusionScan | ESCA | TCGA-IG-A97H-01A | CHMP1A-FANCA | Out-of-Frame | chr16:89723989 | chr16:89851372 |
| Chimerdb3.0 | FusionScan | ESCA | TCGA-L5-A8NI-01A | ANKRD11-FANCA | 5'UTR-CDS | chr16:89556652 | chr16:89818630 |
| Chimerdb3.0 | FusionScan | ESCA | TCGA-L5-A8NI-01A | ANKRD11-FANCA | 5'UTR-CDS | chr16:89556652 | chr16:89825113 |
| Chimerdb3.0 | FusionScan | ESCA | TCGA-L5-A8NI-01A | ANKRD11-FANCA | 5'UTR-CDS | chr16:89497663 | chr16:89818630 |
| TCGAfusionPortal | PRADA | LUAD | TCGA-78-7161-01A | FANCA-CACNA2D4 | 5UTR-CDS | Chr16:89818546 | Chr12:1955855 |
| TCGAfusionPortal | PRADA | LUAD | TCGA-97-8176-01A | ANKRD11-FANCA | 5UTR-5UTR | Chr16:89484692 | Chr16:89818630 |
| Top |
| TissGeneNet for FANCA |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| BRCA (tumor) | BRCA (normal) |
| FANCA, SMARCA4, SRC, CCT3, CDK1, CD79A, TCERG1, PCNA, BLM, FANCL, FANCF, FANCG, NUB1, FANCC, MSH2, SMARCC1, CENPE, HPRT1, LIPG, FANCB, SNX5 (tumor) | FANCA, SMARCA4, PLCG1, SRC, CDK1, TCERG1, PCNA, TCP1, BLM, ENO1, FANCL, FANCG, FANCC, FANCE, POLN, MSH2, CENPE, HPRT1, PSMA5, TPT1, FANCB (normal) |
 |  |
| COAD (tumor) | COAD (normal) |
| FANCA, BRCA1, HSP90B1, CDK1, DAXX, PIK3R1, ATR, PCNA, RMI1, BLM, ENO1, FANCG, TOP3A, FANCM, FANCC, STRA13, MSH2, C19orf40, CENPE, LIPG, FANCB (tumor) | FANCA, NCK1, SMARCA4, BRCA1, CDK1, TCERG1, PRPF31, RMI1, BLM, ENO1, FANCG, FANCM, FANCC, FANCE, STRA13, MSH2, C17orf70, APITD1, CENPE, TPT1, FANCB (normal) |
 |  |
| HNSC (tumor) | HNSC (normal) |
| FANCA, DNAJB1, SMARCA4, BRCA1, SRC, CDK1, DAXX, PIK3R1, PCNA, NPM1, SMARCD3, ENO1, ATP5B, GNB2, FANCG, CAPN1, FANCE, STRA13, CENPE, TPT1, FANCB (tumor) | FANCA, BRCA1, CDK1, KRT1, TCERG1, PCNA, RPA1, RMI1, BLM, FANCL, FANCG, TOP3A, FANCM, FANCC, FANCE, MSH2, C19orf40, APITD1, CENPE, FANCB, DUS4L (normal) |
 |  |
| KICH (tumor) | KICH (normal) |
| FANCA, GRB2, CCT3, CDK1, FYN, PCNA, CRK, TAF10, RMI1, RPL18, SMARCD3, FANCF, ZNF24, FANCC, FANCE, IFIT3, SMARCC1, HPRT1, PSMA5, TPT1, DUS4L (tumor) | FANCA, NCK1, BRCA1, PLCG1, CDK1, TCERG1, PCNA, RMI1, BLM, RPL18, ENO1, ATP5B, FANCG, TOP3A, FANCC, FANCE, IFIT3, C19orf40, CENPE, FANCB, DUS4L (normal) |
 |  |
| KIRC (tumor) | KIRC (normal) |
| FANCA, BRCA1, HSP90B1, CDK1, KRT1, TCERG1, PCNA, AZIN1, NAMPT, SPTA1, NPM1, SGK1, BLM, SMARCD3, FANCL, ATP5B, FANCG, APITD1, CENPE, FANCB, SNX5 (tumor) | FANCA, BRCA1, GRB2, SRC, CDK1, CD79A, TCERG1, ATR, PCNA, CRK, TAF10, BLM, FANCG, ZNF24, TOP3A, C19orf40, C17orf70, CENPE, MKNK1, PSMA5, FANCB (normal) |
 |  |
| KIRP (tumor) | KIRP (normal) |
| FANCA, IKBKB, CHUK, AZIN1, NAMPT, ERCC4, BLM, SMARCD3, FANCL, GNB2, FANCG, NUB1, CAPN1, FANCC, FANCE, IFIT3, C17orf70, APITD1, LIPG, MX1, SNX5 (tumor) | FANCA, BRCA1, PLCG1, SRC, IKBKB, CDK1, TCERG1, CHUK, PCNA, TAF10, BLM, FANCL, ATP5B, ALDOA, FANCG, STRA13, C19orf40, C17orf70, CENPE, FANCB, SNX5 (normal) |
 |  |
| LIHC (tumor) | LIHC (normal) |
| FANCA, DNAJB1, PLCG1, IKBKB, PCNA, AZIN1, NAMPT, CRK, RPA1, SGK1, SMARCD3, FANCL, FANCG, NUB1, CAPN1, MSH2, IFIT3, C19orf40, TPT1, MX1, DUS4L (tumor) | FANCA, BRCA1, CDK1, PCNA, CRK, RMI1, BLM, ENO1, FANCG, FANCC, FANCE, POLN, MSH2, IFIT3, C19orf40, APITD1, CENPE, MKNK1, PSMA5, TPT1, FANCB (normal) |
 |  |
| LUAD (tumor) | LUAD (normal) |
| FANCA, GRB2, SRC, CD79A, DAXX, PIK3R1, PRPF31, PCNA, CRK, TAF10, BLM, ENO1, ALDOA, GNB2, FANCG, ZNF24, FANCM, FANCE, C19orf40, C17orf70, MKNK1 (tumor) | FANCA, BRCA1, CDK1, TCERG1, PIK3R1, ATR, PCNA, CRK, BLM, SMARCD3, FANCL, FANCG, TOP3A, FANCM, FANCC, MSH2, C19orf40, CENPE, TPT1, FANCB, DUS4L (normal) |
 |  |
| LUSC (tumor) | LUSC (normal) |
| FANCA, BRCA1, GRB2, IKBKB, CDK1, CD79A, ATR, PCNA, NAMPT, CRK, RMI1, BLM, FANCL, FANCG, FANCM, FANCE, POLN, MSH2, C19orf40, CENPE, FANCB (tumor) | FANCA, BRCA1, PLCG1, CDK1, TCERG1, ATR, PRPF31, PCNA, CRK, BLM, FANCL, FANCG, TOP3A, FANCM, FANCC, MSH2, C19orf40, C17orf70, CENPE, TPT1, FANCB (normal) |
 |  |
| PRAD (tumor) | PRAD (normal) |
| FANCA, NCK1, BRCA1, GRB2, IKBKB, CDK1, CD79A, TCERG1, ATR, PCNA, BLM, ENO1, HES1, FANCG, CAPN1, TOP3A, FANCC, MSH2, C17orf70, CENPE, FANCB (tumor) | FANCA, BRCA1, PLCG1, CDK1, CD79A, TCERG1, PCNA, BLM, ENO1, FANCG, TOP3A, FANCM, FANCC, FANCE, MSH2, C17orf70, CENPE, HPRT1, TPT1, FANCB, DUS4L (normal) |
 |  |
| STAD (tumor) | STAD (normal) |
| FANCA, SRC, CDK1, CD79A, DAXX, PIK3R1, PCNA, SGK1, TAF10, ERCC4, RMI1, BLM, SMARCD3, ENO1, FANCF, GNB2, FANCG, FANCC, C19orf40, MX1, SNX5 (tumor) | FANCA, SMARCA4, BRCA1, HSP90B1, CDK1, TCERG1, PCNA, RMI1, BLM, SMARCD3, ENO1, FANCL, FANCG, TOP3A, FANCM, FANCC, FANCE, MSH2, CENPE, PSMA5, FANCB (normal) |
 |  |
| THCA (tumor) | THCA (normal) |
| FANCA, GRB2, CCT3, CDK1, CD79A, KRT1, DAXX, PCNA, TAF10, BLM, ENO1, NUB1, ZNF24, IFIT3, APITD1, CENPE, PSMA5, LIPG, MX1, SNX5, DUS4L (tumor) | FANCA, SMARCA4, HSP90B1, CDK1, CD79A, FYN, PCNA, NAMPT, BLM, FANCG, CAPN1, IFIT3, APITD1, CENPE, MKNK1, PSMA5, LIPG, FANCB, MX1, SNX5, DUS4L (normal) |
 |  |
| Top |
| TissGeneProg for FANCA |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for FANCA |
| TissGeneDrug for FANCA |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for FANCA |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 82 | BeFree,CLINVAR,MGD,UNIPROT |
| umls:C0015625 | Fanconi Anemia | 81 | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET |
| umls:C0006142 | Malignant neoplasm of breast | 10 | BeFree,GAD |
| umls:C0268490 | Tyrosinemia, Type I | 9 | BeFree |
| umls:C0023467 | Leukemia, Myelocytic, Acute | 5 | BeFree,LHGDN |
| umls:C0678222 | Breast Carcinoma | 5 | BeFree |
| umls:C0005684 | Malignant neoplasm of urinary bladder | 2 | BeFree,GAD |
| umls:C0007137 | Squamous cell carcinoma | 2 | BeFree,LHGDN |
| umls:C0268483 | Tyrosinemias | 2 | BeFree |
| umls:C0677886 | Epithelial ovarian cancer | 2 | BeFree,GAD |
| umls:C0000768 | Congenital Abnormality | 1 | BeFree |
| umls:C0005695 | Bladder Neoplasm | 1 | CTD_human |
| umls:C0007847 | Malignant tumor of cervix | 1 | BeFree |
| umls:C0009402 | Colorectal Carcinoma | 1 | BeFree |
| umls:C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| umls:C0016689 | Freckles | 1 | GWASCAT |
| umls:C0018939 | Hematological Disease | 1 | BeFree |
| umls:C0023470 | Myeloid Leukemia | 1 | BeFree |
| umls:C0023890 | Liver Cirrhosis | 1 | BeFree |
| umls:C0023895 | Liver diseases | 1 | BeFree |
| umls:C0024117 | Chronic Obstructive Airway Disease | 1 | GAD |
| umls:C0025202 | melanoma | 1 | BeFree |
| umls:C0025517 | Metabolic Diseases | 1 | BeFree |
| umls:C0028259 | Nodule | 1 | BeFree |
| umls:C0029925 | Ovarian Carcinoma | 1 | BeFree |
| umls:C0030297 | Pancreatic Neoplasm | 1 | LHGDN |
| umls:C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
| umls:C0042900 | Vitiligo | 1 | GWASCAT |
| umls:C0151779 | Cutaneous Melanoma | 1 | BeFree |
| umls:C0220615 | Adult Acute Myeloblastic Leukemia | 1 | BeFree |
| umls:C0242379 | Malignant neoplasm of lung | 1 | GAD |
| umls:C0275814 | Streptococcal lymphadenitis of swine | 1 | BeFree |
| umls:C0280100 | Solid tumour | 1 | BeFree |
| umls:C0302592 | Cervix carcinoma | 1 | BeFree |
| umls:C0596263 | Carcinogenesis | 1 | BeFree |
| umls:C0598766 | Leukemogenesis | 1 | BeFree |
| umls:C0699885 | Carcinoma of bladder | 1 | BeFree |
| umls:C0851140 | Carcinoma in situ of uterine cervix | 1 | GAD |
| umls:C0919267 | ovarian neoplasm | 1 | LHGDN |
| umls:C1140680 | Malignant neoplasm of ovary | 1 | BeFree,GAD |
| umls:C1527249 | Colorectal Cancer | 1 | BeFree |
| umls:C1623038 | Cirrhosis | 1 | BeFree |
| umls:C2919093 | caffeine stimulant related disorder | 1 | GAD |
| umls:C3539878 | Triple Negative Breast Neoplasms | 1 | BeFree |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |